EBT Innovation - A Key Enabler For Employees To Return To Work

ProcessMAP > Risk & Compliance > Winning COVID-19 Blog 2: EBT Innovation – A Key Enabler For Employees To Return To Work

While companies around the world have grappled with the challenge of managing through the COVID-19 crisis, ProcessMAP Corporation, the industry leader in offering a data intelligence platform for employee Health and Safety, and Environmental Sustainability (EHS), has been conducting one of the largest EHS leadership roundtable – Winning COVID-19 with ProcessMAP – on a weekly basis.

As ProcessMAP customers make plans for returning employees to work, new safety concerns come into play. With elevated body temperature being one of the most common symptoms of the novel coronavirus, being able to detect and monitor Elevated Body Temperature (EBT) in the workplace is one-way EHS professionals can help to prevent the spread of the virus within the workplace. Of concern are large throughput areas where people pass for entry into a work environment, e.g. airports, businesses, warehouses and factories, and the ability to detect EBT among these people.

One company working to address the need for EBT screening is ProcessMAP customer Johnson Controls, Inc. (JCI), which operates in more than 200 countries with more than 105,000 employees worldwide. JCI offers a range of solutions that optimize building performance to improve safety, enhance comfort, and increase sustainability.

During ProcessMAP’s roundtable, we heard from Ted Hall, who serves as the Global Program Manager for the Innovation Team at JCI. He and his team in the Center of Excellence Network are currently researching and testing EBT screening solutions to help their customers be able to bring their employees back to work and help them to stay healthy in their work environments.

The Innovation Team has evaluated more than 70 products to find the most effective, efficient tools to screen groups of people as they enter facilities. They have worked to ensure the products comply with the National Defense Authorization Act (NDAA) and are Food & Drug Administration (FDA) 510K approved. As guidelines change, the JCI Innovation Team has had to adapt their requirements accordingly. The JCI solution is expected to be available later in May.

Thank you, Ted and the entire team at Johnson Controls, for your commitment to innovation, and to keep your own 105,000 employees and the employees of your customers safe and healthy.

The Winning COVID-19 with ProcessMAP weekly forum continues to bring together distinguished EHS leaders from Fortune 1000 companies, experts from the fields of public health, legal, and technology sectors to share effective strategies, best practices, and innovative solutions to minimize the impact of COVID-19 pandemic on employee safety and business operations.

This blog is a part of a new series of curated content that ProcessMAP will be sharing with the larger EHS community. Watch this space for our next blog! To read our previous blog in this series, Click Here!

#StaySafe